I am a Hematologist and Medical Oncologist at the UT Tyler School of Medicine in Tyler, Texas, where I serve as the Associate Program Director of the Hematology
Comparative survival after Neoadjuvant vs Adjuvant systemic therapy in resectable stage II and stage III non-small cell lung cancer: A retrospective study using National Cancer Database.
.@RepJohnKatko @gillibrandny@SenSchumer Help bolster the US healthcare workforce by supporting the bipartisan Healthcare Workforce Resilience Act (HR 2255 / S 1024)!
@stolaney1 Hi Dr. Tolany, this is hemeonc fellow at SUNY Upstate Medical University. I wanted to ask you what treatment do you offer for metastatic hormone positive breast cancer in visceral crisis with diffuse liver and bony mets and bilirubin 15.
Thanks
Ghanshyam